Skinny Shot

Skinny Shot

Adam J Cohen, MD and The Aesthetic Lounge are committed to helping people reach their ideal body goals and to do so, achieving the ideal weight prior to surgery is key to our success. In the past we would request patients lose weight and come back when they have done so for their surgery. This has changed with the new medications that have recently become available for patients. The skinny shot can help you reach your goals and is part of our comprehensive approach for our patients.


You will begin with an initial consultation. This can be done specifically for weight loss or in combination with your surgical consultation.

You will be evaluated and the risks and benefits of the medications will be discussed.

Once your treatment plan has been established, you will start on once weekly injections.

The medications have to be titrated to an effective dose.

You will have monthly visits at our office to check your progress and adjust your medication dosage.

The goal of including Semaglutide treatment with your surgical procedure is to help you achieve your ideal body weight prior to surgery for the best possible aesthetic result.


Semaglutide is a GLP -1 receptor agonist, that means it acts like a glucagon like peptide. This drug was first designed as treatment for diabetic patients, however it was found to have profound weight loss properties in patients. This was a huge benefit to diabetic patients, but also the population as a whole. The GLP-1 was shown to affect appetite and food intake. It decreases a person’s appetite which in turn leads to weight loss. The first medication on the market was Ozempic. Because of its effectiveness on weight loss as well as a newer medication called Wegovy, it has been released for the treatment of obesity. Both medications are Semaglutide. Semaglutide is administered via a weekly injection that patients can do in the comfort of their own home.

Semaglutide has proven to be extremely effective in several studies. One of the first studies evaluating the effectiveness of Semaglutides included more than 1,000 patients. These patients were treated for 68 weeks and lost an average of 15% of their body weight (with an average weight loss of 35 pounds).

A second study that included 900+ patients showed that patients on average lost 17% of their body weight (an average of 41 pounds) at 68 weeks. It is important to remember that everyone in these studies were counseled on improving dietary habits and increasing physical activity. The results of these studies are truly exciting for our patients.
Many medications have come and gone to treat obesity. Side effects were experienced with led to disappointing results. In Semaglutide clinical trials for the treatment of weight loss, patients experienced few side effects during the 68-week treatment. Over 90% of patients that started treatment completed their 68-week treatment course.

The most common adverse issues were gastrointestinal issues such nausea and diarrhea. In general, semaglutide is extremely well tolerated.

  • Patients that are overweight or obese.
  • Patients that want to decrease their weight and improve their overall health.
  • Patients who are not diabetic or currently on any diabetic medications.
  • Patients who do not have a history of thyroid cancer.
  • Patients who do not have any pancreatic issues.
  • Patients who have realistic expectations that the best results are when Semaglutides are combined with lifestyle changes that include diet and exercise.
  • Patients who want to improve their overall appearance.
  • Patients wanting to reach their ideal body weight prior to surgery are great candidates for as this will improve their overall results.
Lets Talk

Ready to schedule your beauty treatment?

We also offer free consultations.

Ready to schedule your beauty treatment?

We also offer free consultations.

Call Now Button